Capecitabine
- Product NDC
- 50268-154
- 11-digit product format
- 502680154
- Labeler code
- 50268
- Product ID
- 50268-154_d5ce9e94-5ce8-0aab-e053-2a95a90a6819
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Capecitabine
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- AvPAK
- Application
- ANDA204741
- Marketing category
- ANDA
- Marketing start
- 2018-03-12
- Marketing end
- 0000-00-00
- Substance
- CAPECITABINE
- Active strength
- 500 mg/1
- Pharmacologic classes
- Nucleic Acid Synthesis Inhibitors [MoA], Nucleoside Metabolic Inhibitor [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2023-12-31
- Current FDA listing
- Historical FDA.report record
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 50268-154-13 | 50268015413 | 30 BLISTER PACK in 1 BOX, UNIT-DOSE (50268-154-13) > 1 TABLET in 1 BLISTER PACK (50268-154-11) | 30 blister pack | 2018-03-12 | 0000-00-00 | No | No | Current |